51.91
-1.41 (-2.64%)
| 前收盘价格 | 53.32 |
| 收盘价格 | 53.05 |
| 成交量 | 1,748,730 |
| 平均成交量 (3个月) | 2,932,755 |
| 市值 | 9,792,198,656 |
| 预期市盈率 (P/E Forward) | 2.50 |
| 价格/销量 (P/S) | 2.98 |
| 股市价格/股市净资产 (P/B) | 3.60 |
| 52周波幅 | |
| 利润日期 | 30 Jul 2025 |
| 营业毛利率 | -36.06% |
| 营业利益率 (TTM) | -11.53% |
| 稀释每股收益 (EPS TTM) | -5.53 |
| 季度收入增长率 (YOY) | 10.90% |
| 总债务/股东权益 (D/E MRQ) | 105.93% |
| 流动比率 (MRQ) | 2.73 |
| 营业现金流 (OCF TTM) | 323.66 M |
| 杠杆自由现金流 (LFCF TTM) | 163.08 M |
| 资产报酬率 (ROA TTM) | -1.83% |
| 股东权益报酬率 (ROE TTM) | -36.89% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Diagnostics & Research (US) | 混合的 | 混合的 |
| Diagnostics & Research (全球的) | 混合的 | 混合的 | |
| 股票 | Exact Sciences Corporation | 看跌 | 看跌 |
AIStockmoo 评分
| 分析师共识 | -0.5 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | -2.0 |
| 平均 | -0.50 |
|
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact’s Cologuard screening test, a noninvasive stool-based DNA test, is a precancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening. |
|
| 部门 | Healthcare |
| 行业 | Diagnostics & Research |
| 投资方式 | Small Growth |
| 内部持股比例 | 0.92% |
| 机构持股比例 | 98.89% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 64.00 (Evercore ISI Group, 23.29%) | 购买 |
| 中 | 57.50 (10.77%) | |
| 低 | 46.00 (RBC Capital, -11.39%) | 保留 |
| 平均值 | 56.33 (8.52%) | |
| 总计 | 4 购买, 2 保留 | |
| 平均价格@调整类型 | 42.19 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| BTIG | 12 Aug 2025 | 60.00 (15.58%) | 购买 | 41.74 |
| Piper Sandler | 11 Aug 2025 | 60.00 (15.58%) | 购买 | 40.91 |
| Evercore ISI Group | 08 Aug 2025 | 64.00 (23.29%) | 购买 | 40.99 |
| 08 Jul 2025 | 68.00 (31.00%) | 购买 | 53.54 | |
| Barclays | 07 Aug 2025 | 55.00 (5.95%) | 购买 | 43.16 |
| 24 Jun 2025 | 65.00 (25.22%) | 购买 | 51.17 | |
| RBC Capital | 07 Aug 2025 | 46.00 (-11.39%) | 保留 | 43.16 |
| UBS | 07 Aug 2025 | 53.00 (2.10%) | 保留 | 43.16 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合